Boxer Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-100,000
Closed -$14.6M – 62
2023
Q3
$14.6M Hold
100,000
– – 0.78% 38
2023
Q2
$23.1M Buy
+100,000
New +$27.1M 1.07% 32
2018
Q3
– Sell
-95,000
Closed -$26.6M – 25
2018
Q2
$26.6M Buy
+95,000
New +$16.7M 3.01% 13

Other funds holding MDGL

Boxer Capital Management's MDGL Position: Q4 2023 in Review

Boxer Capital Management sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2023, closing a stake of 100,000 shares — an estimated $14.6M sold.

Boxer Capital Management first reported a position in MDGL in Q2 2018 and held it in 3 quarters. The position peaked at $26.6M in Q2 2018. 226 funds tracked by Wall St. Rank hold MDGL as of Q4 2023.

  • Boxer Capital Management reported no remaining Madrigal Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Boxer Capital Management sold 100,000 Madrigal Pharmaceuticals shares in Q4 2023, an estimated $14.6M.
  • Boxer Capital Management first reported a position in Madrigal Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Boxer Capital Management's Madrigal Pharmaceuticals position peaked at $26.6M in Q2 2018.
  • 226 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2023.

Based on Boxer Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.